MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-15-2023
Invacare Corporation Operating Expenses 2011-2026 | IVC
Annual Operating Expenses Invacare Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 260 M | 282 M | 297 M | 304 M | 320 M | 384 M | 402 M | 415 M | 446 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 446 M | 260 M | 345 M |
Operating Expenses of other stocks in the Medical devices industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AdaptHealth Corp.
AHCO
|
59.6 M | $ 13.17 | 0.46 % | $ 1.78 B |  USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
Eargo
EAR
|
126 M | - | - | $ 10.2 M | USA |
 |
Delcath Systems
DCTH
|
72.8 M | $ 10.8 | 4.05 % | $ 387 M | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
40.3 M | $ 25.6 | -0.43 % | $ 216 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.47 | 4.52 % | $ 130 M |  France |
 |
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
Helius Medical Technologies
HSDT
|
12.5 M | $ 2.12 | 3.92 % | $ 1.29 M | USA |
 |
Inspire Medical Systems
INSP
|
240 M | $ 56.7 | 1.0 % | $ 1.67 B | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
LivaNova PLC
LIVN
|
697 M | $ 61.0 | 1.5 % | $ 3.33 B |  Britain |
 |
ClearPoint Neuro
CLPT
|
15.3 M | $ 11.37 | 1.7 % | $ 322 M | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.61 | 0.36 % | $ 38 M | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
IRIDEX Corporation
IRIX
|
21.8 M | $ 1.03 | - | $ 17.4 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
OrthoPediatrics Corp.
KIDS
|
212 M | $ 15.65 | 3.92 % | $ 367 M | USA |
 |
Butterfly Network
BFLY
|
123 M | $ 5.4 | 12.97 % | $ 1.14 B | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
Sintx Technologies
SINT
|
11.2 M | $ 2.41 | 14.22 % | $ 6.68 M | USA |
 |
Globus Medical
GMED
|
547 M | $ 91.34 | 1.29 % | $ 12.4 B | USA |
 |
TransMedics Group
TMDX
|
254 M | $ 100.01 | -0.77 % | $ 3.4 B | USA |
 |
NanoVibronix
NAOV
|
23 M | - | - | $ 1.08 M | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 36.8 | 0.38 % | $ 1.14 B | USA |
 |
Integer Holdings Corporation
ITGR
|
279 M | $ 84.03 | -5.06 % | $ 2.92 B | USA |
 |
Stryker Corporation
SYK
|
11.2 B | $ 294.73 | -6.47 % | $ 113 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.99 B | $ 83.98 | 0.57 % | $ 49.1 B | USA |
 |
Tandem Diabetes Care
TNDM
|
159 M | $ 19.41 | -0.61 % | $ 1.32 B | USA |
 |
LENSAR
LNSR
|
32.6 M | $ 5.61 | 7.27 % | $ 67.1 M | USA |
 |
Pulmonx Corporation
LUNG
|
121 M | $ 1.35 | 5.47 % | $ 54.9 M | USA |
 |
MiMedx Group
MDXG
|
277 M | $ 3.68 | 9.52 % | $ 544 M | USA |
 |
Myomo
MYO
|
41.3 M | $ 0.9 | 4.16 % | $ 37.7 M | USA |